Found 233 hits with Last Name = 'asahi' and Initial = 's' Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173629
(CHEMBL197912 | Cyclopentyl-[4-(2-ethyl-4-m-tolyl-t...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC2CCCC2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C22H25N3S/c1-3-20-25-21(16-8-6-7-15(2)13-16)22(26-20)17-11-12-23-19(14-17)24-18-9-4-5-10-18/h6-8,11-14,18H,3-5,9-10H2,1-2H3,(H,23,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173614
(CHEMBL196575 | [4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)...)Show SMILES CCc1nc(c(s1)-c1ccnc(NCCc2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C25H25N3S/c1-3-23-28-24(20-11-7-8-18(2)16-20)25(29-23)21-13-15-27-22(17-21)26-14-12-19-9-5-4-6-10-19/h4-11,13,15-17H,3,12,14H2,1-2H3,(H,26,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358192
(CHEMBL1921975)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)[C@@](O)(C(C)C)c1cnc[nH]1 |r| Show InChI InChI=1S/C19H21N3O2/c1-12(2)19(24,17-10-21-11-22-17)16-7-6-13-8-15(18(23)20-3)5-4-14(13)9-16/h4-12,24H,1-3H3,(H,20,23)(H,21,22)/t19-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.5 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173627
(CHEMBL197581 | N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-y...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)Cc2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C25H23N3OS/c1-3-23-28-24(19-11-7-8-17(2)14-19)25(30-23)20-12-13-26-21(16-20)27-22(29)15-18-9-5-4-6-10-18/h4-14,16H,3,15H2,1-2H3,(H,26,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5.60 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Rattus norvegicus (Rat)) | BDBM50338363
(CHEMBL1682893 | rac-6-[1-Hydroxy-1-(1H-imidazol-4-...)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)C(O)(C(C)C)c1cnc[nH]1 Show InChI InChI=1S/C19H21N3O2/c1-12(2)19(24,17-10-21-11-22-17)16-7-6-13-8-15(18(23)20-3)5-4-14(13)9-16/h4-12,24H,1-3H3,(H,20,23)(H,21,22) | KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 6.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of Sprague-Dawley rat testicular microsomal CYP17A1 using [1,2-3H]-17a-hydroxyprogesterone as substrate after 15 m... |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173621
(Benzyl-[4-(2-ethyl-4-m-tolyl-thiazol-5-yl)-pyridin...)Show SMILES CCc1nc(c(s1)-c1ccnc(NCc2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C24H23N3S/c1-3-22-27-23(19-11-7-8-17(2)14-19)24(28-22)20-12-13-25-21(15-20)26-16-18-9-5-4-6-10-18/h4-15H,3,16H2,1-2H3,(H,25,26) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 6.70 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173609
(CHEMBL363648 | D3RKN_11 | N-[4-(2-Ethyl-4-m-tolyl-...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 7.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Geranylgeranyl transferase type-1 subunit beta/Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
(Homo sapiens (Human)) | BDBM50109937
((R)-2-[(Indane-2-carbonyl)-amino]-3-naphthalen-1-y...)Show SMILES SCCCOC(=O)[C@@H](Cc1cccc2ccccc12)NC(=O)C1Cc2ccccc2C1 Show InChI InChI=1S/C26H27NO3S/c28-25(22-15-19-8-1-2-9-20(19)16-22)27-24(26(29)30-13-6-14-31)17-21-11-5-10-18-7-3-4-12-23(18)21/h1-5,7-12,22,24,31H,6,13-17H2,(H,27,28)/t24-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 7.30 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute
Curated by ChEMBL
| Assay Description Tested for the inhibition of Candida GGTase I in Candida albicans |
Bioorg Med Chem Lett 12: 629-32 (2002)
BindingDB Entry DOI: 10.7270/Q2251HGT |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173606
(CHEMBL198383 | Cyclohexanecarboxylic acid [4-(2-et...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)C2CCCCC2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C24H27N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h7-8,11-15,17H,3-6,9-10H2,1-2H3,(H,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 7.90 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173617
(CHEMBL381864 | [4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)...)Show SMILES CCc1nc(c(s1)-c1ccnc(NCCCc2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C26H27N3S/c1-3-24-29-25(21-13-7-9-19(2)17-21)26(30-24)22-14-16-28-23(18-22)27-15-8-12-20-10-5-4-6-11-20/h4-7,9-11,13-14,16-18H,3,8,12,15H2,1-2H3,(H,27,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173633
(CHEMBL194201 | N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-y...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)CCc2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C26H25N3OS/c1-3-24-29-25(20-11-7-8-18(2)16-20)26(31-24)21-14-15-27-22(17-21)28-23(30)13-12-19-9-5-4-6-10-19/h4-11,14-17H,3,12-13H2,1-2H3,(H,27,28,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173622
(CHEMBL199160 | N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-y...)Show InChI InChI=1S/C20H21N3OS/c1-4-17(24)22-16-12-15(9-10-21-16)20-19(23-18(5-2)25-20)14-8-6-7-13(3)11-14/h6-12H,4-5H2,1-3H3,(H,21,22,24) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 8.80 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50405453
(CHEMBL5271309)Show SMILES CC(C)CCn1c(=O)n(CC(C)C)c2ccc3[nH]cnc3c2c1=O Show InChI InChI=1S/C18H24N4O2/c1-11(2)7-8-21-17(23)15-14(22(18(21)24)9-12(3)4)6-5-13-16(15)20-10-19-13/h5-6,10-12H,7-9H2,1-4H3,(H,19,20) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| | n/a | n/a | 8.90 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173626
(CHEMBL382103 | {4-[2-(4-Methanesulfonyl-phenyl)-4-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccnc(NCCc2ccccc2)c1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C30H27N3O2S2/c1-21-7-6-10-24(19-21)28-29(36-30(33-28)23-11-13-26(14-12-23)37(2,34)35)25-16-18-32-27(20-25)31-17-15-22-8-4-3-5-9-22/h3-14,16,18-20H,15,17H2,1-2H3,(H,31,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 9.10 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Geranylgeranyl transferase type-1 subunit beta/Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
(Homo sapiens (Human)) | BDBM50109938
(9H-Xanthene-9-carboxylic acid {(R)-2-(3,4-dichloro...)Show SMILES Clc1ccc(C[C@@H](NC(=O)C2c3ccccc3Oc3ccccc23)C(=O)NCCc2cnc[nH]2)cc1Cl Show InChI InChI=1S/C28H24Cl2N4O3/c29-21-10-9-17(13-22(21)30)14-23(27(35)32-12-11-18-15-31-16-33-18)34-28(36)26-19-5-1-3-7-24(19)37-25-8-4-2-6-20(25)26/h1-10,13,15-16,23,26H,11-12,14H2,(H,31,33)(H,32,35)(H,34,36)/t23-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
| PubMed
| n/a | n/a | 10 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute
Curated by ChEMBL
| Assay Description Inhibition of Candida geranylgeranyl transferase I at 3 uM |
Bioorg Med Chem Lett 12: 629-32 (2002)
BindingDB Entry DOI: 10.7270/Q2251HGT |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173611
(Benzyl-{4-[2-(4-methanesulfonyl-phenyl)-4-m-tolyl-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccnc(NCc2ccccc2)c1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C29H25N3O2S2/c1-20-7-6-10-23(17-20)27-28(35-29(32-27)22-11-13-25(14-12-22)36(2,33)34)24-15-16-30-26(18-24)31-19-21-8-4-3-5-9-21/h3-18H,19H2,1-2H3,(H,30,31) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173623
(CHEMBL383569 | N-[4-(2-Methyl-4-m-tolyl-thiazol-5-...)Show SMILES Cc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C23H19N3OS/c1-15-7-6-10-18(13-15)21-22(28-16(2)25-21)19-11-12-24-20(14-19)26-23(27)17-8-4-3-5-9-17/h3-14H,1-2H3,(H,24,26,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173607
(CHEMBL197545 | N-[4-(2-Propyl-4-m-tolyl-thiazol-5-...)Show SMILES CCCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(C)c1 Show InChI InChI=1S/C25H23N3OS/c1-3-8-22-28-23(19-12-7-9-17(2)15-19)24(30-22)20-13-14-26-21(16-20)27-25(29)18-10-5-4-6-11-18/h4-7,9-16H,3,8H2,1-2H3,(H,26,27,29) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173638
(CHEMBL197772 | N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-y...)Show SMILES CCCC(=O)Nc1cc(ccn1)-c1sc(CC)nc1-c1cccc(C)c1 Show InChI InChI=1S/C21H23N3OS/c1-4-7-18(25)23-17-13-16(10-11-22-17)21-20(24-19(5-2)26-21)15-9-6-8-14(3)12-15/h6,8-13H,4-5,7H2,1-3H3,(H,22,23,25) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358195
(CHEMBL1921979)Show InChI InChI=1S/C18H17N3O/c1-19-18(22)15-5-3-12-8-14(4-2-13(12)9-15)16-6-7-21-11-20-10-17(16)21/h2-5,8-11,16H,6-7H2,1H3,(H,19,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 13 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173630
(4-[2-(4-Methanesulfonyl-phenyl)-4-m-tolyl-thiazol-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccncc1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C22H18N2O2S2/c1-15-4-3-5-18(14-15)20-21(16-10-12-23-13-11-16)27-22(24-20)17-6-8-19(9-7-17)28(2,25)26/h3-14H,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 14 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Rattus norvegicus (Rat)) | BDBM50358195
(CHEMBL1921979)Show InChI InChI=1S/C18H17N3O/c1-19-18(22)15-5-3-12-8-14(4-2-13(12)9-15)16-6-7-21-11-20-10-17(16)21/h2-5,8-11,16H,6-7H2,1H3,(H,19,22) | KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of Sprague-Dawley rat testicular microsomal CYP17A1 using [1,2-3H]-17a-hydroxyprogesterone as substrate after 15 m... |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173628
(4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridine | CHEM...)Show InChI InChI=1S/C17H16N2S/c1-3-15-19-16(14-6-4-5-12(2)11-14)17(20-15)13-7-9-18-10-8-13/h4-11H,3H2,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50338363
(CHEMBL1682893 | rac-6-[1-Hydroxy-1-(1H-imidazol-4-...)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)C(O)(C(C)C)c1cnc[nH]1 Show InChI InChI=1S/C19H21N3O2/c1-12(2)19(24,17-10-21-11-22-17)16-7-6-13-8-15(18(23)20-3)5-4-14(13)9-16/h4-12,24H,1-3H3,(H,20,23)(H,21,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Geranylgeranyl transferase type-1 subunit beta/Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
(Homo sapiens (Human)) | BDBM50109933
(2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazole-4-c...)Show InChI InChI=1S/C16H17NO5S3/c18-10(6-23)14(7-24)22-16(19)9-8-25-15(17-9)13-5-20-11-3-1-2-4-12(11)21-13/h1-4,8,10,13-14,18,23-24H,5-7H2 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute
Curated by ChEMBL
| Assay Description Tested for the inhibition of Candida GGTase I in Candida albicans |
Bioorg Med Chem Lett 12: 629-32 (2002)
BindingDB Entry DOI: 10.7270/Q2251HGT |
More data for this Ligand-Target Pair | |
Geranylgeranyl transferase type-1 subunit beta/Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
(Homo sapiens (Human)) | BDBM50109933
(2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazole-4-c...)Show InChI InChI=1S/C16H17NO5S3/c18-10(6-23)14(7-24)22-16(19)9-8-25-15(17-9)13-5-20-11-3-1-2-4-12(11)21-13/h1-4,8,10,13-14,18,23-24H,5-7H2 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 17 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute
Curated by ChEMBL
| Assay Description Tested for the inhibition of Candida GGTase I in Candida albicans |
Bioorg Med Chem Lett 12: 629-32 (2002)
BindingDB Entry DOI: 10.7270/Q2251HGT |
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50405449
(CHEMBL5266711)Show SMILES COCc1nc2c(ccc3n(CC(C)C)c(=O)n(C)c(=O)c23)[nH]1 Show InChI InChI=1S/C16H20N4O3/c1-9(2)7-20-11-6-5-10-14(18-12(17-10)8-23-4)13(11)15(21)19(3)16(20)22/h5-6,9H,7-8H2,1-4H3,(H,17,18) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50239947
(CHEMBL4089730 | US20230303494, Compound BMS202 | U...)Show SMILES COc1nc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O Show InChI InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Similars
| | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50239943
(CHEMBL4099869 | US9872852, Example 8)Show SMILES Cc1c(COc2ccc(CN3CCCCC3C(O)=O)cc2Br)cccc1-c1ccccc1 Show InChI InChI=1S/C27H28BrNO3/c1-19-22(10-7-11-23(19)21-8-3-2-4-9-21)18-32-26-14-13-20(16-24(26)28)17-29-15-6-5-12-25(29)27(30)31/h2-4,7-11,13-14,16,25H,5-6,12,15,17-18H2,1H3,(H,30,31) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Patents
Similars
| | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50239947
(CHEMBL4089730 | US20230303494, Compound BMS202 | U...)Show SMILES COc1nc(OCc2cccc(c2C)-c2ccccc2)ccc1CNCCNC(C)=O Show InChI InChI=1S/C25H29N3O3/c1-18-22(10-7-11-23(18)20-8-5-4-6-9-20)17-31-24-13-12-21(25(28-24)30-3)16-26-14-15-27-19(2)29/h4-13,26H,14-17H2,1-3H3,(H,27,29) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Similars
| | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50405450
(CHEMBL5315609)Show InChI InChI=1S/C15H18N4O2/c1-8(2)7-19-11-6-5-10-13(17-9(3)16-10)12(11)14(20)18(4)15(19)21/h5-6,8H,7H2,1-4H3,(H,16,17) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| | n/a | n/a | 18 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358201
(CHEMBL1921976 | US9611270, orteronel)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12 |r| Show InChI InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173612
(4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridin-2-ylami...)Show InChI InChI=1S/C17H17N3S/c1-3-15-20-16(12-6-4-5-11(2)9-12)17(21-15)13-7-8-19-14(18)10-13/h4-10H,3H2,1-2H3,(H2,18,19) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 20 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50405449
(CHEMBL5266711)Show SMILES COCc1nc2c(ccc3n(CC(C)C)c(=O)n(C)c(=O)c23)[nH]1 Show InChI InChI=1S/C16H20N4O3/c1-9(2)7-20-11-6-5-10-14(18-12(17-10)8-23-4)13(11)15(21)19(3)16(20)22/h5-6,9H,7-8H2,1-4H3,(H,17,18) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| | n/a | n/a | 22 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Rattus norvegicus (Rat)) | BDBM50358197
(CHEMBL1921981)Show InChI InChI=1S/C17H15N3O2/c18-16(21)13-2-1-12-8-14(4-3-11(12)7-13)17(22)5-6-20-10-19-9-15(17)20/h1-4,7-10,22H,5-6H2,(H2,18,21) | KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 24 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of Sprague-Dawley rat testicular microsomal CYP17A1 using [1,2-3H]-17a-hydroxyprogesterone as substrate after 15 m... |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173608
(CHEMBL371920 | N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-y...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(C)=O)c1)-c1cccc(C)c1 Show InChI InChI=1S/C19H19N3OS/c1-4-17-22-18(14-7-5-6-12(2)10-14)19(24-17)15-8-9-20-16(11-15)21-13(3)23/h5-11H,4H2,1-3H3,(H,20,21,23) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173616
(4-[2-(4-Methanesulfonyl-phenyl)-4-m-tolyl-thiazol-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccnc(C)c1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C23H20N2O2S2/c1-15-5-4-6-18(13-15)21-22(19-11-12-24-16(2)14-19)28-23(25-21)17-7-9-20(10-8-17)29(3,26)27/h4-14H,1-3H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 26 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358197
(CHEMBL1921981)Show InChI InChI=1S/C17H15N3O2/c18-16(21)13-2-1-12-8-14(4-3-11(12)7-13)17(22)5-6-20-10-19-9-15(17)20/h1-4,7-10,22H,5-6H2,(H2,18,21) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 29 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173637
(CHEMBL194595 | N-{4-[4-(3-Chloro-phenyl)-2-ethyl-t...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1cccc(Cl)c1 Show InChI InChI=1S/C23H18ClN3OS/c1-2-20-27-21(16-9-6-10-18(24)13-16)22(29-20)17-11-12-25-19(14-17)26-23(28)15-7-4-3-5-8-15/h3-14H,2H2,1H3,(H,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 30 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173618
(CHEMBL371188 | N-[4-(2-Ethyl-4-phenyl-thiazol-5-yl...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1ccccc1 Show InChI InChI=1S/C23H19N3OS/c1-2-20-26-21(16-9-5-3-6-10-16)22(28-20)18-13-14-24-19(15-18)25-23(27)17-11-7-4-8-12-17/h3-15H,2H2,1H3,(H,24,25,27) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173619
(CHEMBL425909 | N-{4-[2-Ethyl-4-(4-fluoro-phenyl)-t...)Show SMILES CCc1nc(c(s1)-c1ccnc(NC(=O)c2ccccc2)c1)-c1ccc(F)cc1 Show InChI InChI=1S/C23H18FN3OS/c1-2-20-27-21(15-8-10-18(24)11-9-15)22(29-20)17-12-13-25-19(14-17)26-23(28)16-6-4-3-5-7-16/h3-14H,2H2,1H3,(H,25,26,28) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Geranylgeranyl transferase type-1 subunit beta/Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha
(Homo sapiens (Human)) | BDBM50109940
(2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazole-4-c...)Show InChI InChI=1S/C15H15NO5S2/c17-9(7-22)5-20-15(18)10-8-23-14(16-10)13-6-19-11-3-1-2-4-12(11)21-13/h1-4,8-9,13,17,22H,5-7H2 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD antibodypedia antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 31 | n/a | n/a | n/a | n/a | n/a | n/a |
Banyu Tsukuba Research Institute
Curated by ChEMBL
| Assay Description Tested for the inhibition of Candida GGTase I in Candida albicans |
Bioorg Med Chem Lett 12: 629-32 (2002)
BindingDB Entry DOI: 10.7270/Q2251HGT |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173632
(CHEMBL197799 | N-{4-[2-(4-Methanesulfonyl-phenyl)-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccnc(NC(=O)Cc2ccccc2)c1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C30H25N3O3S2/c1-20-7-6-10-23(17-20)28-29(37-30(33-28)22-11-13-25(14-12-22)38(2,35)36)24-15-16-31-26(19-24)32-27(34)18-21-8-4-3-5-9-21/h3-17,19H,18H2,1-2H3,(H,31,32,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173613
(CHEMBL371716 | N-{4-[2-(4-Methanesulfonyl-phenyl)-...)Show SMILES Cc1cccc(c1)-c1nc(sc1-c1ccnc(NC(=O)c2ccccc2)c1)-c1ccc(cc1)S(C)(=O)=O Show InChI InChI=1S/C29H23N3O3S2/c1-19-7-6-10-22(17-19)26-27(36-29(32-26)21-11-13-24(14-12-21)37(2,34)35)23-15-16-30-25(18-23)31-28(33)20-8-4-3-5-9-20/h3-18H,1-2H3,(H,30,31,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358193
(CHEMBL1921977)Show InChI InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Patents
Similars
| PDB Article PubMed
| n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Platelet-derived growth factor receptor alpha/beta
(Mus musculus (mouse)) | BDBM50405450
(CHEMBL5315609)Show InChI InChI=1S/C15H18N4O2/c1-8(2)7-19-11-6-5-10-13(17-9(3)16-10)12(11)14(20)18(4)15(19)21/h5-6,8H,7H2,1-4H3,(H,16,17) | MMDB
KEGG
UniProtKB/SwissProt
DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| | n/a | n/a | 43 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description Concentration at which the clotting time was prolonged by twice that of the control by inhibiting thrombin |
Citation and Details
|
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Homo sapiens (Human)) | BDBM50358202
(CHEMBL1921985)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)[C@]1(O)CCn2cncc12 |r| Show InChI InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m1/s1 | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of human CYP17A1 |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Rattus norvegicus (Rat)) | BDBM50358201
(CHEMBL1921976 | US9611270, orteronel)Show SMILES CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12 |r| Show InChI InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1 | KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
CHEMBL MCE PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 48 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of Sprague-Dawley rat testicular microsomal CYP17A1 using [1,2-3H]-17a-hydroxyprogesterone as substrate after 15 m... |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |
Mitogen-activated protein kinase 14
(Homo sapiens (Human)) | BDBM50173636
(4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-2-methyl-pyridi...)Show InChI InChI=1S/C18H18N2S/c1-4-16-20-17(14-7-5-6-12(2)10-14)18(21-16)15-8-9-19-13(3)11-15/h5-11H,4H2,1-3H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 53 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against mitogen-activated protein kinase p38 alpha |
J Med Chem 48: 5966-79 (2005)
Article DOI: 10.1021/jm050165o BindingDB Entry DOI: 10.7270/Q2G160DZ |
More data for this Ligand-Target Pair | |
Steroid 17-alpha-hydroxylase/17,20 lyase
(Rattus norvegicus (Rat)) | BDBM50358193
(CHEMBL1921977)Show InChI InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22) | KEGG
UniProtKB/SwissProt
GoogleScholar AffyNet
| Purchase
CHEMBL PC cid PC sid PDB UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
Takeda Pharmaceutical Company, Ltd.
Curated by ChEMBL
| Assay Description Inhibition of 17,20-lyase activity of Sprague-Dawley rat testicular microsomal CYP17A1 using [1,2-3H]-17a-hydroxyprogesterone as substrate after 15 m... |
Bioorg Med Chem 19: 6383-99 (2011)
Article DOI: 10.1016/j.bmc.2011.08.066 BindingDB Entry DOI: 10.7270/Q2X63NDF |
More data for this Ligand-Target Pair | |